Raleigh Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65
Closed -$1K 850
2022
Q3
$1K Buy
+65
New +$1.31K ﹤0.01% 756

Other funds holding MD

Raleigh Capital Management's MD Position: Q4 2022 in Review

Raleigh Capital Management sold out of Pediatrix Medical (MD) in Q4 2022, closing a stake of 65 shares — an estimated $1K sold.

Raleigh Capital Management first reported a position in MD in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 209 funds tracked by Wall St. Rank hold MD as of Q4 2022.

  • Raleigh Capital Management reported no remaining Pediatrix Medical position as of Q4 2022 after selling out during the quarter.
  • Raleigh Capital Management sold 65 Pediatrix Medical shares in Q4 2022, an estimated $1K.
  • Raleigh Capital Management first reported a position in Pediatrix Medical in Q3 2022 and held it in 1 quarter.
  • Raleigh Capital Management's Pediatrix Medical position peaked at $1K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2022.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.